Enveric Biosciences (ENVB) Short Interest Ratio & Short Volume → BREAKING – Pentagon to Spend $20 Billion on “Distributed AI” (From Behind the Markets) (Ad) Free ENVB Stock Alerts $0.88 -0.01 (-1.09%) (As of 11:09 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Enveric Biosciences Short Interest DataCurrent Short Volume95,600 sharesPrevious Short Volume254,900 sharesChange Vs. Previous Month-62.50%Dollar Volume Sold Short$88,095.40Short Interest Ratio / Days to Cover0.0Last Record DateApril 15, 2024Outstanding Shares7,290,000 sharesFloat Size6,820,000 sharesShort Percent of Float1.40%Today's Trading Volume17,219,737 sharesAverage Trading Volume3,310,533 sharesToday's Volume Vs. Average520% Short Selling Enveric Biosciences ? Sign up to receive the latest short interest report for Enveric Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatENVB Short Interest Over TimeENVB Days to Cover Over TimeENVB Percentage of Float Shorted Over Time Ad The Tomorrow InvestorThe Department of Defense Has a New Drone ContractorThe Department of Defense just granted a major advantage to a small UAV provider. Since 1998, this Nasdaq-listed company has been supplying drones for civilian, enterprise, and military purposes.Click here to see how to invest Enveric Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/202495,600 shares $88,095.40 -62.5%1.4%0 $0.92 3/31/2024254,900 shares $254,900.00 +69.5%4.2%0.1 $1.00 3/15/2024150,400 shares $162,432.00 +58.2%3.2%0 $1.08 2/29/202495,100 shares $137,895.00 +47.0%4.2%0 $1.45 2/15/202464,700 shares $54,283.30 +181.3%2.5%0.2 $0.84 1/31/202423,000 shares $16,932.60 -58.6%0.9%0.2 $0.74 Get the Latest News and Ratings for ENVB and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Enveric Biosciences and its competitors with MarketBeat's FREE daily newsletter. 1/15/202455,600 shares $71,168.00 +334.4%2.3%1.4 $1.28 12/31/202312,800 shares $16,640.00 +6.7%0.6%0.4 $1.30 12/15/202312,000 shares $16,080.00 +263.6%0.6%0.7 $1.34 11/30/20233,300 shares $4,884.00 -54.8%0.2%0.2 $1.48 11/15/20237,300 shares $10,402.50 -62.4%0.4%0.4 $1.43 10/31/202319,400 shares $33,368.00 -19.5%1.0%0.9 $1.72 10/15/202324,100 shares $50,851.00 +121.1%1.3%0.3 $2.11 9/30/202310,900 shares $25,942.00 -55.0%0.6%0.1 $2.38 9/15/202324,200 shares $55,176.00 -45.3%1.2%0.3 $2.28 8/31/202344,200 shares $95,472.00 -42.3%2.3%0.4 $2.16 8/15/202376,600 shares $182,308.00 +86.4%4.0%0.1 $2.38 7/31/202341,100 shares $109,737.00 +95.7%2.2%0 $2.67 7/15/202321,000 shares $60,270.00 -43.1%1.1%0 $2.87 6/30/202336,900 shares $124,353.00 -65.6%2.0%0 $3.37 6/15/2023107,400 shares $414,564.00 -69.1%5.8%0 $3.86 5/31/2023347,300 shares $1.46 million +1,430.0%18.7%0.1 $4.19 5/15/202322,700 shares $34,050.00 -30.2%1.2%0 $1.50 4/30/202332,500 shares $59,520.50 +44.4%1.8%1 $1.83 4/15/202322,500 shares $34,200.00 +39.8%1.2%0.6 $1.52 3/31/202316,100 shares $26,793.62 +64.3%0.9%0.6 $1.66 3/15/20239,800 shares $16,954.00 +71.9%0.6%0.3 $1.73 2/28/20235,700 shares $11,913.00 -38.0%0.3%0.1 $2.09 2/15/20239,200 shares $24,932.00 -37.8%0.5%0.2 $2.71 1/31/202314,800 shares $42,476.00 -53.6%0.8%0.3 $2.87 1/15/202331,900 shares $90,277.00 -21.2%1.7%0.7 $2.83 12/30/202240,500 shares $84,240.00 -11.2%2.0%0.7 $2.08 12/15/202245,600 shares $97,584.00 +27.4%2.3%0.9 $2.14 11/30/202235,800 shares $102,746.00 -17.5%1.8%0.5 $2.87 11/15/202243,400 shares $147,560.00 -37.7%2.2%0.4 $3.40 10/31/202269,700 shares $237,677.00 +36.1%4.7%0.3 $3.41 10/15/202251,200 shares $175,104.00 +55.2%3.6%0.1 $3.42 9/30/202233,000 shares $139,260.00 -60.1%2.3%0.1 $4.22 9/15/202282,800 shares $477,756.00 +11.7%5.8%0.2 $5.77 8/31/202274,100 shares $413,478.00 -21.7%5.4%0.2 $5.58Incredible Opportunity to Retire FAST! (Ad)A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.Click here to get instant access to the guide ENVB Short Interest - Frequently Asked Questions What is Enveric Biosciences' current short interest? Short interest is the volume of Enveric Biosciences shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 95,600 shares of ENVB short. 1.40% of Enveric Biosciences' shares are currently sold short. Learn More on Enveric Biosciences' current short interest. What is a good short interest percentage for Enveric Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.40% of Enveric Biosciences' floating shares are currently sold short. Is Enveric Biosciences' short interest increasing or decreasing? Enveric Biosciences saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 95,600 shares, a drop of 62.5% from the previous total of 254,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Enveric Biosciences' float size? Enveric Biosciences currently has issued a total of 7,290,000 shares. Some of Enveric Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Enveric Biosciences currently has a public float of 6,820,000 shares. How does Enveric Biosciences' short interest compare to its competitors? 1.40% of Enveric Biosciences' shares are currently sold short. Here is how the short interest of companies compare to Enveric Biosciences: Shuttle Pharmaceuticals Holdings, Inc. (0.77%), TFF Pharmaceuticals, Inc. (2.77%), Adial Pharmaceuticals, Inc. (26.72%), Pulmatrix, Inc. (0.32%), Cadrenal Therapeutics, Inc. (2.04%), Xenetic Biosciences Inc (0.22%), Pasithea Therapeutics Corp. (1.34%), Lixte Biotechnology Holdings, Inc. (4.59%), Vaccinex, Inc. (2.99%), Trevena, Inc. (0.33%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Enveric Biosciences stock? Short selling ENVB is an investing strategy that aims to generate trading profit from Enveric Biosciences as its price is falling. ENVB shares are trading down $0.03 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Enveric Biosciences? A short squeeze for Enveric Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of ENVB, which in turn drives the price of the stock up even further. How often is Enveric Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ENVB, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Shuttle Pharmaceuticals Short Interest TFF Pharmaceuticals Short Interest Adial Pharmaceuticals Short Interest Pulmatrix Short Interest Cadrenal Therapeutics Short Interest Xenetic Biosciences Short Interest Pasithea Therapeutics Short Interest Lixte Biotechnology Short Interest Vaccinex Short Interest Trevena Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ENVB) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorFidelity, Bezos, Goldman Bet Big on Tiny BiotechBehind the MarketsElon Musk Secret Crypto Plot ExposedCrypto 101 MediaAI “wealth window” is closing June 25thParadigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressGold Set to EXPLODE!Gold Safe ExchangeThe AI Stock that’s Disrupting Every IndustryStockEarningsThe #1 lithium battery stock to have on your radar in 2024!Smallcaps Daily